Acurx Pharmaceuticals, Inc. - COM (ACXP)

Q3 2021 13F Holders as of 9/30/2021

Type / Class
Equity / COM
Number of holders
7
Total 13F shares, excl. options
64.7K
Shares change
+39.2K
Total reported value, excl. options
$332K
Value change
+$182K
Number of buys
7
Number of sells
-1
Price
$5.13

Significant Holders of Acurx Pharmaceuticals, Inc. - COM (ACXP) as of Q3 2021

8 filings reported holding ACXP - Acurx Pharmaceuticals, Inc. - COM as of Q3 2021.
Acurx Pharmaceuticals, Inc. - COM (ACXP) has 7 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 64.7K shares .
Largest 8 shareholders include MILLENNIUM MANAGEMENT LLC (30.1K shares), TOCQUEVILLE ASSET MANAGEMENT L.P. (19.1K shares), BlackRock Inc. (6.52K shares), Patriot Financial Group Insurance Agency, LLC (4K shares), ADVISOR GROUP HOLDINGS, INC. (3K shares), Semmax Financial Advisors Inc. (1.26K shares), Tower Research Capital LLC (TRC) (707 shares), and PARSONS CAPITAL MANAGEMENT INC/RI (0 shares).
This table shows the top 7 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.